Oak Harbor Wealth Partners LLC Acquires 629 Shares of CME Group Inc. (NASDAQ:CME)

Oak Harbor Wealth Partners LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 7.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,156 shares of the financial services provider’s stock after buying an additional 629 shares during the quarter. Oak Harbor Wealth Partners LLC’s holdings in CME Group were worth $2,020,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the second quarter valued at about $36,000. McClarren Financial Advisors Inc. grew its stake in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares during the period. Asset Dedication LLC increased its holdings in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co bought a new position in shares of CME Group in the 2nd quarter worth $76,000. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock valued at $3,441,063 over the last quarter. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CME. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Deutsche Bank Aktiengesellschaft dropped their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday. Citigroup upped their price target on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Oppenheimer upped their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Finally, TD Cowen began coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Price Performance

Shares of NASDAQ:CME opened at $223.42 on Friday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36. The company has a 50-day moving average price of $222.44 and a 200 day moving average price of $210.17. The company has a market cap of $80.45 billion, a P/E ratio of 23.49, a PEG ratio of 5.26 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.25 EPS. Research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.06%. CME Group’s payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.